N02.4 Recurrent and persistent hematuria with diffuse endocapillary proliferative glomerulonephritis

Name of the Condition

• Recurrent and Persistent Hematuria with Diffuse Endocapillary Proliferative Glomerulonephritis
• ICD-10 Code: N02.4

Summary

Recurrent and persistent hematuria with diffuse endocapillary proliferative glomerulonephritis is a kidney condition marked by repeated or ongoing blood in the urine, associated with inflammation and proliferation of cells within the glomerular capillaries. This type of glomerulonephritis involves immune-mediated damage to the kidney's filtering structures, which can affect kidney function over time.

Causes

The exact cause of diffuse endocapillary proliferative glomerulonephritis is often unclear but may result from immune complex deposition or infections, such as post-streptococcal glomerulonephritis. It can also be triggered by autoimmune responses or other systemic conditions that affect the kidneys.

Risk Factors

• Infections: Prior or current infections, particularly bacterial or viral infections.
• Autoimmune Conditions: Underlying autoimmune diseases that target the kidneys.
• Genetic Predisposition: Family history of glomerulonephritis or kidney disease.
• Age: More common in children and young adults, though it can occur at any age.

Symptoms

• Visible blood in the urine (hematuria), which may be intermittent or persistent.
• Proteinuria (excess protein in urine) in some cases.
• Hypertension (high blood pressure) due to kidney involvement.
• Swelling (edema) in the legs, ankles, or face.
• Fatigue or reduced urine output in severe cases.

Diagnosis

Diagnosis typically involves a urinalysis to confirm hematuria and assess for proteinuria. Additional tests may include blood tests to evaluate kidney function (e.g., creatinine, BUN), imaging studies (e.g., ultrasound) to rule out structural abnormalities, and a kidney biopsy to identify the specific type of glomerulonephritis and assess the extent of damage.

Treatment Options

Treatment focuses on managing symptoms and addressing the underlying cause. This may include medications to control blood pressure (e.g., ACE inhibitors or ARBs), immunosuppressive therapies to reduce inflammation, and antibiotics if an infection is identified. In severe cases, dialysis or kidney transplantation may be necessary.

Prognosis and Follow-Up

The prognosis varies depending on the severity of kidney damage and response to treatment. Early intervention can improve outcomes, but some individuals may experience progressive kidney dysfunction over time. Regular monitoring of kidney function and blood pressure is essential to detect complications early.

Complications

• Progressive kidney failure requiring dialysis or transplantation.
• Chronic hypertension.
• Proteinuria leading to nephrotic syndrome.
• Increased risk of infections due to impaired kidney function.

Lifestyle & Prevention

• Maintain a balanced diet low in sodium and protein to reduce kidney strain.
• Stay hydrated to support urinary tract health.
• Avoid medications that may harm the kidneys (e.g., certain NSAIDs) unless prescribed.
• Manage underlying conditions like hypertension or diabetes to reduce kidney stress.

When to Seek Professional Help

Seek medical attention if you experience persistent blood in the urine, unexplained swelling, severe fatigue, or changes in urine output. Prompt evaluation is important to identify and treat the underlying cause before complications develop.

Tips for Medical Coders

When coding for N02.4, ensure documentation supports the diagnosis of recurrent and persistent hematuria with diffuse endocapillary proliferative glomerulonephritis. Include details about the presence of hematuria, biopsy findings confirming the glomerulonephritis type, and any associated symptoms or complications. Verify that the code aligns with the clinical documentation to avoid miscoding.